A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer

Published 2020 View Full Article

Authors

Keywords

immunotherapy, epitope spread, metastatic cancer, NEO-PV-01, cancer vaccine, T cell, neoantigen, personalized vaccine, checkpoint inhibitor, anti-PD-1

Journal

CELL

Volume 183, Issue 2, Pages 347-362.e24

Publisher

Elsevier BV

Online

2020-10-15

DOI

10.1016/j.cell.2020.08.053

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now